Aprepitant vs. Multimodal Prophylaxis in the Prevention of Nausea and Vomiting following Extended-Release Epidural Morphine

消炎药 医学 麻醉 止吐药 昂丹司琼 恶心 术后恶心呕吐 呕吐 地塞米松 尼美舒利 内科学
作者
Craig T. Hartrick,Yeong-Shiuh Tang,David A. Hunstad,John R. Pappas,Kathy Muir,Cecile Pestano,Daniel Silvasi
出处
期刊:Pain Practice [Wiley]
卷期号:10 (3): 245-248 被引量:21
标识
DOI:10.1111/j.1533-2500.2010.00364.x
摘要

Background: Extended-release epidural morphine (EREM) is an effective option for postoperative analgesia following major orthopedic surgery; however, postoperative nausea/vomiting (PONV) is a recognized limitation. The incidence of PONV following prophylactic aprepitant, a neurokinin-1 antagonist, was compared with prophylactic multimodal antiemetic therapy in patients receiving EREM for postoperative analgesia following unilateral primary total knee arthroplasty (TKA). Methods: Prospectively collected quality assurance data were examined with Institutional Review Board approval. A sequential, open-label, active matched case-control study compared PONV following EREM in patients receiving ondansetron and dexamethasone, and either metoclopramide, diphenhydramine, or prochlorperazine every 6 hours for the 48-hour study period, to patients receiving aprepitant 40 mg given as a single oral dose in the preoperative holding area. Cases were matched for procedure (TKA), age, epidural morphine dose, and known major risk factors for PONV (sex, smoking, previous PONV/motion sickness). Results: Twelve consecutive patients (3 male; 9 female) receiving aprepitant prior to EREM were matched to 12 patients of the same sex of similar age (range 51 to 84 years.) and EREM dose (range 5 to 12.5 mg) receiving the multimodal regime. The incidence of PONV was significantly less for the aprepitant group where 3 of 12 (25%) had PONV compared with 9 of 12 (75%) in the multimodal group (P = 0.039, Fisher's Exact Test; odds ratio = 0.11; 95% CI: 0.018 to 0.706, P = 0.03). Conclusion: While aprepitant significantly reduced the incidence of PONV compared with a multimodal antiemetic regime, used alone it did not eliminate PONV.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
EstAffectus发布了新的文献求助30
1秒前
1秒前
情怀的应助被PENG采纳,获得10
3秒前
呆萌的山柏完成签到,获得积分10
4秒前
cencen发布了新的文献求助10
4秒前
jumbaumba完成签到,获得积分10
5秒前
俏皮以旋完成签到,获得积分10
5秒前
www完成签到,获得积分10
6秒前
CodeCraft的应助被傅纶军采纳,获得10
6秒前
NexusExplorer的应助被公西钧采纳,获得10
6秒前
小于发布了新的文献求助10
7秒前
7秒前
谦让的沛蓝发布了新的文献求助100
7秒前
科研通AI6.3的应助被zombie采纳,获得10
8秒前
俏皮以旋发布了新的文献求助10
10秒前
11秒前
猪猪完成签到 ,获得积分10
11秒前
噜妹完成签到 ,获得积分10
11秒前
隐形曼青的应助被456qwe采纳,获得10
11秒前
Huang完成签到 ,获得积分0
12秒前
13秒前
斯文败类的应助被Lu采纳,获得10
13秒前
Hello的应助被小于采纳,获得10
13秒前
niuniuniu发布了新的文献求助10
13秒前
顾矜的应助被zhang采纳,获得10
14秒前
椰子汁完成签到,获得积分10
14秒前
chenyi完成签到 ,获得积分10
15秒前
疯狂的聋五完成签到,获得积分10
15秒前
77发布了新的文献求助10
15秒前
16秒前
Wyf发布了新的文献求助10
16秒前
17秒前
18秒前
20秒前
jcz完成签到,获得积分10
20秒前
21秒前
科研通AI6.2的应助被cencen采纳,获得10
22秒前
公西钧发布了新的文献求助10
22秒前
傅纶军发布了新的文献求助10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573479
关于积分的说明 21831986
捐赠科研通 7781752
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962